Position in ABT
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$124,572,046
-$367,828 QoQ
Shares Held
1,372,846
+49.4% QoQ
Ownership
0.079%
of shares outstanding
% of Portfolio
0.95%
of 13F equity value
Holder Rank
#113
of 2,959 holders
Holding Since
Mar 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABT Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Freestone Grove Partners LP holds $226,892,211 across 21 Medical Devices names. ABT ranks #1 (54.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
This page
|
1,372,846 | $124,572,046 | |
| 2 | BIO |
Bio-Rad Laboratories, Inc.
|
140,113 | $41,138,577 | |
| 3 | TNDM |
Tandem Diabetes Care Inc
|
1,866,134 | $28,159,962 | |
| 4 | EW |
Edwards Lifesciences Corp
|
171,081 | $15,475,987 | |
| 5 | ATEC |
Alphatec Holdings, Inc.
|
1,173,065 | $10,147,012 | |
| 6 | ALMR |
Alamar Biosciences, Inc.
|
60,000 | $1,625,400 | |
| 7 | PODD |
Insulet Corp
|
10,140 | $1,543,815 | |
| 8 | BSX |
Boston Scientific Corp
|
28,720 | $1,225,769 |
All Filings in ABT
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $124,572,046 | 1,372,846 | Shares | Sole | 2026-08-14 | |
| 2025-06-30 | $124,939,874 | 918,608 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $12,055,629 | 90,883 | Shares | Sole | 2025-05-15 | |
| No filing history on record for this holder in this stock. | ||||||